The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial of temsirolimus and lenalidomide in pts with rel/ref lymphomas.
Sonali M. Smith
Consultant or Advisory Role - Celgene
Kenneth Stuart Cohen
No relevant relationships to disclose
Justin Paul Kline
No relevant relationships to disclose
Jose D Zavala
No relevant relationships to disclose
Kathy Conner
No relevant relationships to disclose
Sachdev P Thomas
No relevant relationships to disclose
Patricia Lesho
No relevant relationships to disclose
Laurence A. Doyle
No relevant relationships to disclose
Walter Michael Stadler
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Theodore Karrison
No relevant relationships to disclose
Amy Sarah Kimball
No relevant relationships to disclose